Company Overview
American HealthCare Capital is pleased to exclusively introduce a Medicare certified hospice agency for sale in San Antonio, Texas. The company was established in 2018, and they are CHAP accredited. They currently serve patients within 60 miles of their office within DADS Region 8.
Financial Overview
The company’s current payer mix is 94% Medicare and 6% Medicaid. In 2022, gross revenues were $1,133,060 with Adjusted EBITDA of $236,368 (20.86%). In 2023, gross revenues grew to $1,466,527 with Adjusted EBITDA of $166,058 (11.32%). In 2024, gross revenues grew again to $1,832,639 with Adjusted EBITDA of $225,237 (12.29%). Through 9/30/25, gross revenues were $1,103,674 with Net Income of $62,986, putting them on track to reach approximately $1,400,000 for FYE 2025.
Census Data
Their current census is 26, and their average daily census ranges from 26-35 patients. The company receives 10-15 referrals per month, resulting in 3-4 admissions. Their ALOS is currently 150 days, though the company has implemented a plan of action to decrease it. There are no outstanding ADRs.
Referrals and Growth Opportunities
Referral sources include LTC facilities, LTAC facilities, VA, and hospitals. Opportunities for growth include expanding their service area in rural and high development areas.
Staff Overview and Exit Plan
The agency runs with limited involvement from the sellers. The sellers intend to pursue other business interests after the sale but will assist with a smooth transition. All existing employees are expecting to remain with a new owner.
Additional Hospice License
Included in the sale is the license and provider number for another hospice, which was licensed by the state in 2023 and received CHAP accreditation and Medicare Certification in 2024. This hospice has no census or employees and has generated no revenue.
Asking Price
The asking price for this opportunity is $2 Million, which excludes cash, receivables, and working capital.
